Saneca Pharma appoints CEO Richard Král

Contract development and manufacturing organisation, Saneca Pharma has inducted the appointment of new CEO, Richard Král.

Prior to this, Richard has been the sales and marketing director at Saneca for almost 3 years and has previously been associated with GlaxoSmithKline and Zentiva Group across the Central and Eastern Europe (CEE) and the Commonweath of Independent States (CIS) regions possessing over 17 years of experience in the pharmaceutical sector and FMCG.

Richard Král will be held accountable for implementing Saneca’s business growth strategy driving operational efficiency and ensuring effective project delivery across the business.

Richard Král said: “I am delighted to be appointed as CEO of Saneca. Over the last three years I have developed a comprehensive understanding of the company and I am looking forward to continuing to drive its success and establishing Saneca as the go-to CDMO in Europe.”